Arthritis and similar conditions affect more than 10 million people in the UK. These inflammatory conditions can significantly limit mobility, comfort, and daily activity.
Some patients may try a range of standard treatments and still struggle to manage certain ongoing symptoms. As a result, medical cannabis has become a topic of interest for some patients who continue to cope with discomfort, stiffness, and inflammation.
This guide explores what arthritis is, common treatments, how medical cannabis might fit for approved patients, and what to expect if you choose to speak with a clinician.
Disclaimer: this page summarizes current information, but it is not a replacement for medical advice. Always consult a qualified healthcare professional before changing any treatment.
What Is Arthritis?
“Arthritis” is an umbrella term for conditions that cause joint pain, stiffness, and inflammation. The most common form of arthritis in the UK is osteoarthritis, affecting nearly 9 million people. This is a condition where the joint cartilage gradually breaks down.
The second most common types of arthritis are inflammatory diseases, such as rheumatoid arthritis, in which the immune system mistakenly attacks the lining of the joints.
Common arthritis-related symptoms include:
- Ongoing joint pain or tenderness
- Morning stiffness or limited mobility
- Swelling, warmth, or redness around joints
- Fatigue and reduced activity levels
- Flare-ups that vary in intensity over time
Symptoms can make daily tasks difficult, and many patients find that the impact on movement and energy builds gradually.
Diagnosing Arthritis
Diagnosis of arthritis typically begins with a review of symptoms, a physical examination, and a discussion about how pain affects daily life.
Depending on the type of arthritis suspected, a clinician may also use:
- X-rays or MRI scans
- Blood tests for inflammatory markers
- Joint fluid analysis
- Assessment of how symptoms change over time
Different forms of arthritis may respond differently to treatment. Getting an accurate diagnosis is an important step before exploring new options.
Current Treatment Paths for Arthritis
Most arthritis patients start with standard therapies such as:
- Pain relievers (paracetamol or NSAIDs)
- Anti-inflammatory medications
- Physiotherapy and targeted exercise
- Lifestyle adjustments and weight management
- Steroid injections or disease-modifying drugs in inflammatory arthritis
These treatments can be helpful, but some patients still experience ongoing pain, reduced joint function, or medication side effects. This is often what leads people to ask what alternatives could play a supportive role in finding relief.
Medical Cannabis in the UK
Medical cannabis has been legal on prescription in the UK since 2018, but guidelines remain cautious. It is not a first-line treatment for arthritis. Instead, clinicians may consider it when:
- A patient has tried established therapies without adequate relief
- Side effects limit the use of other medications
- A specialist believes cannabinoid treatment could be appropriate based on the individual case
Prescriptions must be issued by a specialist doctor, often through a private clinic. Treatment decisions are made on a case-by-case basis, and there is no automatic eligibility based on diagnosis alone.
Some patients report improvements in pain, sleep, or stiffness. However, responses vary because everyone is different. Likewise, treatment is closely monitored.
What Does the Research Say About Cannabis and Arthritis?
Research on medical cannabis and arthritis is still early. Most studies are small or done in labs, with many looking at how cannabis might affect pain and inflammation.
Cannabinoids and Inflammation
Some studies suggest that cannabinoids may help calm certain immune responses linked to arthritis. One review found signs that cannabinoids might help reduce inflammation in joint tissue.1
Lab research shows that THC may lower activity in cells involved in swelling and joint damage.2 These results are early, but they point to possible ways cannabis might influence arthritis symptoms.
Another review found that some people with rheumatoid arthritis report better sleep or less pain when using cannabis. But it also stressed that stronger clinical evidence is still needed.3
A separate study looked at people using CBD for joint pain. Many felt an improvement, though the study was based on self-reports.4
These findings show potential, but we still need larger human studies to understand how well cannabis works for arthritis.
Minor Cannabinoids
Researchers have also studied smaller compounds in the cannabis plant. CBC may help regulate inflammation through a receptor found on immune cells.5
Other studies show that CBD and CBG may reduce inflammatory signals, both individually and in combination.6
These results are interesting, but they have not yet been tested in large trials involving patients with arthritis.
Terpenes in Cannabis
Cannabis also contains natural scent compounds called terpenes that have been studied for their effects on inflammation and pain.
A review found that certain terpenes, such as myrcene, pinene, and linalool, may help reduce pain or inflammation in early research.7 These studies were conducted in animals or cell cultures, so further research in humans is needed.
What This Means for Patients
Right now, research suggests that:
- Cannabinoids may influence inflammation and pain.
- Some patients say they feel better with cannabis-based treatments.
- Most evidence remains preliminary, and individual responses vary.
Because of this, medical cannabis in the UK is usually considered only after standard treatments have been tried.
Doctor Consultation: What to Expect
If you decide to explore medical cannabis, a specialist will review your:
- Medical history, including previous arthritis treatments
- Current medications and overall health
- Daily symptoms and how they affect mobility and quality of life
You’ll also discuss a range of treatment options to determine what may be appropriate for you. This may not include just cannabis.
There is no obligation to start treatment after the consultation. Many patients use the appointment to better understand their options.
FAQs About Medical Cannabis and Arthritis
Can medical cannabis help with joint pain or stiffness?
Some patients report improvements in pain, stiffness, or sleep, especially when traditional treatments haven’t provided enough relief. Responses vary, and clinicians assess this on a case-by-case basis.
Is medical cannabis considered for both osteoarthritis and rheumatoid arthritis?
Possibly. Specialists tend to focus on how severe your symptoms are and what treatments you’ve already tried. The underlying type of arthritis may influence the decision, but it does not guarantee eligibility.
Why isn’t medical cannabis routinely offered for arthritis on the NHS?
NHS prescriptions for medical cannabis remain limited because evidence is still developing and guidelines are cautious. Most patients access medical cannabis through private clinics.
Could medical cannabis interact with my arthritis medications?
It can interact with some medicines, especially those that affect the immune system or cause drowsiness. This is why a specialist reviews your full medication list before prescribing.
Do I need to stop my arthritis medications if I try medical cannabis?
Probably not. Medical cannabis is not typically used as a replacement for disease-modifying or anti-inflammatory treatments. A specialist will review your current regimen to ensure everything works safely together.
Will cannabis help with sleep disrupted by arthritis pain?
Many patients ask this. Some report better sleep quality when pain is managed more effectively. However, results differ between individuals, and improvement is not guaranteed.
How long does it take to know if medical cannabis is helping?
Some patients notice changes within a few weeks, while others require longer. Follow-up appointments help monitor progress and adjust the treatment plan if needed.
Are there age or mobility restrictions for accessing medical cannabis?
There are no set age limits for adults, but specialists consider overall health, frailty, and medication risks when evaluating suitability.
Will I be able to drive if prescribed medical cannabis?
Driving laws still apply. A clinician will explain how to stay compliant with UK regulations, including avoiding impairment and following dosing instructions.
Is treatment expensive?
Costs vary by clinic and product type. Because NHS coverage is rare, most patients pay privately. Clinics typically provide a breakdown of expected monthly costs during your consultation.
Closing: Patient Choice & Compassionate Care
Exploring medical cannabis is a personal decision, and there is no pressure to move forward before you feel ready. A consultation simply gives you space to understand your options, ask questions, and learn what a specialist might recommend.
Your privacy is always respected, and any treatment decisions are based on your needs, goals, and comfort level. You remain in control throughout the process.
Resources
- Lowin T, Schneider M, Pongratz G. Joints for joints: cannabinoids in the treatment of rheumatoid arthritis. Current Opinion in Rheumatology. 2019;31(3):271-278. doi:https://doi.org/10.1097/BOR.0000000000000590 ↩︎
- Lowin T, Kok C, Smutny S, Pongratz G. Impact of Δ9-Tetrahydrocannabinol on Rheumatoid Arthritis Synovial Fibroblasts Alone and in Co-Culture with Peripheral Blood Mononuclear Cells. Biomedicines. 2022;10(5):1118. doi: https://doi.org/10.3390/biomedicines10051118 ↩︎
- Paland N, Hamza H, Pechkovsky A, Aswad M, Shagidov D, Louria-Hayon I. Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions. Rambam Maimonides Med J. 2023;14(4):e0022. Published 2023 Oct 29. doi:10.5041/RMMJ.10509 ↩︎
- Frane, N., Stapleton, E., Iturriaga, C. et al. Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study. J Cannabis Res. 2022;4(47) https://doi.org/10.1186/s42238-022-00154-9 ↩︎
- Udoh M, Santiago M, Devenish S, McGregor IS, Connor M. Cannabichromene is a cannabinoid CB2receptor agonist. British Journal of Pharmacology. 2019;176(23):4537-4547. doi:https://doi.org/10.1111/bph.14815 ↩︎
- Lorena C, Keir-Rudman S, Horniman N, Clarkson N, Page C. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Pulmonary Pharmacology & Therapeutics. 2021;69:102047-102047. doi: https://doi.org/10.1016/j.pupt.2021.102047 ↩︎
- Liktor-Busa E, Keresztes A, LaVigne J, Streicher JM, Largent-Milnes TM. Analgesic Potential of Terpenes Derived from Cannabis sativa. Pharmacological Reviews. 2021;73(4):98-126. doi:https://doi.org/10.1124/pharmrev.120.000046 ↩︎